Global Hemophilia B Market Insights, Epidemiology and Market Forecast 2015-2017 & 2025 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 11, 2018--The “Hemophilia B - Market Insights, Epidemiology and Market Forecast - 2025” drug pipelines has been added to ResearchAndMarkets.com’s offering.
Hemophilia B - Market Insights, Epidemiology and Market Forecast - 2025 provides an overview of the disease and in depth research related to Hemophilia B for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Hemophilia B . It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Hemophilia B for 7 major markets.
The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. Additionally, the report highlights the frontrunners, the drivers and barriers for the Hemophilia B market, as well as treatment algorithm, current treatments & advancements are included. The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Hemophilia B, providing an in-depth analysis of emerging therapies which will create an impact through their launch.
Key Coverage:Understanding historical and forecasted epidemiological data for Hemophilia B covering 7MM from 2015-2025. Segment level epidemiology and market split for Hemophilia B. The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Hemophilia B. The report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2015-2025 and detailed historical and forecasted Hemophilia B market trends. Thorough market distribution based on market share for Hemophilia B.
Key Topics Covered:
1. Report Introduction
2. Hemophilia B Market Overview
3. Hemophilia B at a Glance
4. Epidemiology and Patient Population
5. Treatment Algorithm
6. Marketed Drugs for Hemophilia B
7. Emerging Therapies
8. Overview of Total Hemophilia B Market (2016 & 2025)
9. Hemophilia B: Country-Wise Market Analysis
10. Market Drivers
11. Market Restraints
12. AppendixFor more information about this drug pipelines report visit https://www.researchandmarkets.com/research/ln2f5q/global_hemophilia?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180911005400/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Hematological Drugs
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/11/2018 07:12 AM/DISC: 09/11/2018 07:12 AM